Lombard Odier Asset Management Switzerland SA Makes New $2.30 Million Investment in Synopsys, Inc. $SNPS

Lombard Odier Asset Management Switzerland SA bought a new stake in Synopsys, Inc. (NASDAQ:SNPSFree Report) during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 5,809 shares of the semiconductor company’s stock, valued at approximately $2,303,000.

Several other hedge funds also recently modified their holdings of SNPS. Sankala Group LLC bought a new stake in Synopsys in the fourth quarter worth about $25,000. Thurston Springer Miller Herd & Titak Inc. bought a new stake in shares of Synopsys in the fourth quarter valued at approximately $28,000. Caitong International Asset Management Co. Ltd purchased a new stake in shares of Synopsys during the 4th quarter valued at approximately $28,000. Atlas Capital Advisors Inc. bought a new position in Synopsys in the 4th quarter worth approximately $32,000. Finally, Phillip James Consulting Co. bought a new position in Synopsys in the 4th quarter worth approximately $36,000. Hedge funds and other institutional investors own 85.47% of the company’s stock.

Insider Activity at Synopsys

In related news, CFO Shelagh Glaser sold 3,394 shares of the stock in a transaction dated Friday, June 12th. The shares were sold at an average price of $450.02, for a total transaction of $1,527,367.88. Following the sale, the chief financial officer directly owned 14,358 shares of the company’s stock, valued at approximately $6,461,387.16. This represents a 19.12% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sassine Ghazi sold 14,603 shares of the business’s stock in a transaction that occurred on Monday, June 15th. The stock was sold at an average price of $458.96, for a total transaction of $6,702,192.88. Following the completion of the transaction, the chief executive officer owned 75,020 shares of the company’s stock, valued at approximately $34,431,179.20. The trade was a 16.29% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Corporate insiders own 0.56% of the company’s stock.

Analyst Ratings Changes

Several research analysts have commented on the company. Piper Sandler upgraded Synopsys from a “neutral” rating to an “overweight” rating and raised their target price for the stock from $450.00 to $550.00 in a research note on Tuesday, June 23rd. Benchmark started coverage on Synopsys in a research report on Wednesday, July 15th. They set a “buy” rating and a $570.00 price target on the stock. Bank of America increased their price target on shares of Synopsys from $515.00 to $600.00 and gave the stock a “buy” rating in a report on Thursday, May 28th. Citigroup raised their price objective on shares of Synopsys from $600.00 to $610.00 and gave the company a “buy” rating in a research report on Thursday, May 28th. Finally, Needham & Company LLC reaffirmed a “buy” rating and set a $580.00 price objective on shares of Synopsys in a research note on Thursday, May 28th. Two equities research analysts have rated the stock with a Strong Buy rating, ten have assigned a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $570.06.

Get Our Latest Report on SNPS

Synopsys Price Performance

Shares of Synopsys stock opened at $373.47 on Monday. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.32 and a current ratio of 1.43. Synopsys, Inc. has a 52-week low of $366.00 and a 52-week high of $651.73. The stock has a market capitalization of $71.51 billion, a price-to-earnings ratio of 86.45, a P/E/G ratio of 2.19 and a beta of 1.22. The company’s 50 day moving average price is $456.13 and its 200-day moving average price is $454.98.

Synopsys (NASDAQ:SNPSGet Free Report) last released its quarterly earnings data on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share for the quarter, topping the consensus estimate of $3.15 by $0.20. The business had revenue of $2.28 billion during the quarter, compared to analysts’ expectations of $2.25 billion. Synopsys had a return on equity of 5.83% and a net margin of 8.91%.The business’s revenue was up 41.9% on a year-over-year basis. During the same quarter last year, the business posted $3.67 EPS. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. Equities research analysts forecast that Synopsys, Inc. will post 10.65 EPS for the current year.

Synopsys Profile

(Free Report)

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

Featured Stories

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPSFree Report).

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.